Anti-TNF biosimilars in Crohn's Disease: a patient-centric interdisciplinary approach. [electronic resource]
- Expert review of gastroenterology & hepatology Aug 2019
- 731-738 p. digital
Publication Type: Journal Article; Review
1747-4132
10.1080/17474124.2019.1645595 doi
Adalimumab--administration & dosage Anti-Inflammatory Agents--administration & dosage Antibodies, Monoclonal--administration & dosage Biosimilar Pharmaceuticals--administration & dosage Crohn Disease--diagnosis Drug Costs Drug Monitoring--economics Early Diagnosis Humans Inflammatory Bowel Diseases--economics Patient Care Team Patient-Centered Care--economics Tumor Necrosis Factor-alpha--antagonists & inhibitors